FIELD: pharmaceutics.
SUBSTANCE: invention refers to a compound of formula (I)
EFFECT: invention can be used to develop medicinal agents of cerebroprotective action for treating chronic traumatic encephalopathy.
1 cl, 2 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
| N-(ACETYLSALICYLOYL)PYRAZOL WITH CEREBROPROTECTOR ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2016 |
|
RU2632005C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING NOOTROPIC AND ANTIHYPOXIC ACTIVITY | 2012 |
|
RU2507198C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
| MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| SODIUM SALT OF 4-{ 2-[2-(4- HYDROXY-3-METHOXYPHENYL)-VINYL]-6-ETHYL-4-OXO-5-PHENYL-4H-PYRIMIDINE-1-YL} -BENZENESULFAMIDE, WHICH HAS AN ANTITUMOR EFFECT | 2021 |
|
RU2763899C1 |
| DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
| APPLICATION OF 1-HETARYL-2-NITRO-2-(3-PHENYL-1,2,4-OXADIAZOLE-5-YL)ETHANES AS PSYCHOTROPIC SUBSTANCES | 2009 |
|
RU2420521C1 |
Authors
Dates
2020-01-17—Published
2019-07-29—Filed